- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03344991
Cardboard Cot: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Cardboard Cot in Neonatal Thermoregulation: Prevention of Moderate or Severe Hypothermia in Preterm Infants Assigned to Open Crib
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Following parental consent, preterm infants with an estimated gestational age < 36 6/7 weeks at delivery who have been in an incubator in the newborn ICU for at least 24 hours in settings where an incubator is available, or who are in the newborn ICU in a setting where an incubator is not available, will be randomized to to transfer either standard protocol of open crib or mylar-lined cardboard cot when their temperatures are stable for transfer. The infants will remain in the cot or crib for the duration of the hospital stay. Axillary temperatures will be taken 1 hr, 6 hrs, and 24 hours after being placed in the cot or crib, and then once every 24 hours. All other care is provided as standard of care, including WHO warm chain thermoregulation guidelines of early and exclusive breastfeeding, appropriate bundling and Kangaroo Mother Care as continuously as possible.
If at any point a babies becomes moderately (32.0-35.9° C) or severely hypothermic (< 32.0° C), an extra blanket will be added to their bodies and a hat placed on their heads.
Type d'étude
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Estimated gestational age < 36 6/7 weeks
- Hospitalized in the newborn ICU at University Teaching Hospital
- Nursed in an incubator for at least 24 hours
- Thought to be ready to be weaned from incubator by the clinical staff
Exclusion Criteria:
- Major congenital anomalies
- Requiring ongoing respiratory support
- Suspected sepsis
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Cardboard Cot Care
Stable infant will be transferred to cardboard cot, lined with reflective film for duration of hospital stay following weaning from radiant warmer.
Infant's axillary temperature will be taken at 1 hour, 6 hours, 24 hours after being placed in the cot or crib, and then once every 24 hours until discharge.
|
When ready to be weaned from radiant warmer, infant will be placed in a reflective film-lined cot for the duration of hospitalization.
Axillary temperatures will be taken at 1 hour, 6 hours, and 24 hours after placement in cot, and every 24 hours thereafter until discharge.
If temperatures found < 36.0 at any time, an additional blanket and hat will be added to infant to improve temperature.
All other care will be standard of care at University Teaching Hospital, including early and exclusive breastfeeding, appropriate bundling, and Kangaroo Mother Care as continuously as possible.
|
|
Comparateur placebo: Open Crib
Stable infant will be transferred to standard of care open crib for duration of hospital stay following weaning from radiant warmer.
Infant's axillary temperature will be taken at 1 hour, 6 hours, 24 hours after being placed in the cot or crib, and then once every 24 hours until discharge.
|
When ready to be weaned from radiant warmer, infant will be placed in a standard of care open crib for the duration of hospitalization.
Axillary temperatures will be taken at 1 hour, 6 hours, and 24 hours after placement in cot, and every 24 hours thereafter until discharge.
If temperatures found < 36.0 at any time, an additional blanket and hat will be added to infant to improve temperature.
All other care will be standard of care at University Teaching Hospital, including early and exclusive breastfeeding, appropriate bundling, and Kangaroo Mother Care as continuously as possible.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Moderate (32.0-35.9° C) or Severe (<32.0° C) Hypothermia at discharge per axillary Temperature
Délai: Up to 14 days
|
Up to 14 days
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Hypothermia (< 36.0° C) throughout the duration of the intervention measured by axillary temperature
Délai: Up to14 days
|
Up to14 days
|
|
Mean Axillary Temperatures on All Infants Weaned to Cardboard Cots
Délai: 4 months
|
4 months
|
|
Mean Axillary Temperatures on All Infants Weaned to Open Cribs
Délai: 4 months
|
4 months
|
|
Moderate Hypothermia (32.0-35.9° C) after placement in warming device measured by axillary Temperature
Délai: 1 hour after placement in warming device
|
1 hour after placement in warming device
|
|
Moderate Hypothermia (32.0-35.9° C) after placement in warming device measured by axillary temperature
Délai: 6 hours
|
6 hours
|
|
Moderate Hypothermia (32.0-35.9° C) after placement in warming device measured by axillary temperature
Délai: 24 hours after placement in warming device
|
24 hours after placement in warming device
|
|
Severe (<32.0° C) Hypothermia after placement in the warming device measured by axillary temperature
Délai: 1 hour after placement in warming device
|
1 hour after placement in warming device
|
|
Severe (<32.0° C) Hypothermia after placement in the warming device measured by axillary temperature
Délai: 6 hours after placement in warming device
|
6 hours after placement in warming device
|
|
Severe (<32.0° C) Hypothermia after placement in the warming device measured by axillary temperature
Délai: 24 hours after placement in warming device
|
24 hours after placement in warming device
|
|
Rate of Hyperthemia (>38° C) measured by axillary temperature
Délai: 14 days
|
14 days
|
|
Rate of Normothermia (>36.5° C) at discharge measured by axillary temperature
Délai: Up to 14 days
|
Up to 14 days
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Colm P Travers, MB BCh BAO, University of Alabama at Birmingham
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- UAB Neo 019
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Nourrisson, prématuré
-
Georgetown UniversityComplétéParental Infant Bonding | Stabilité cardio-respiratoire chez les nourrissons prématurés de l'USINÉtats-Unis
Essais cliniques sur Cardboard Cot Care
-
Chinese University of Hong KongComplétéMaladies osseuses | Scoliose; Adolescence | Croissance osseuse anormaleHong Kong
-
Indonesia UniversityComplétéChirurgie post-abdominaleIndonésie
-
Nuvo-Group, Ltd.ComplétéFemmes enceintes en bonne santéÉtats-Unis
-
University of California, San DiegoNational Cancer Institute (NCI); University of Michigan; Arizona State University et autres collaborateursComplétéComportement sédentaire | Inactivité physiqueÉtats-Unis
-
Jens BräunlichRecrutementInsuffisance respiratoire hypercapnique | Insuffisance respiratoire hypoxémique | Bronchite virale aiguëAllemagne
-
Mayo ClinicRésilié
-
Nanfang Hospital, Southern Medical UniversityRecrutementCancer papillaire de la thyroïdeChine
-
Hacettepe UniversityComplétéFatigue | Performance | Cancer infantile | Indépendance fonctionnelleTurquie
-
Montefiore Medical CenterAmerican Academy of Physical Medicine and RehabilitationRésilié
-
Silke Wiegand-Grefe, Prof. Dr.Charite University, Berlin, Germany; Hannover Medical School; University Hospital... et autres collaborateursActif, ne recrute pasMaladies raresAllemagne